跳到正文
10月22日周四
10月21日周三
11月6日周五
11月2日周一
11月14日周六
  1. Rohan Paul73

    Dario Amodei 在纽约 JPMorgan 活动上对谈 Jamie Dimon 时表示,Anthropic 对 IPO 的时机和市场状况并不特别在意。JPMorgan 承销此次纳斯达克上市,定于周四挂牌;Amodei 称上市主要为储备现金,因为算力是公司面临的最深层商业难题。

    引用Rohan Paul@rohanpaul_ai

    Dario Amodei: Anthropic is set to spend $900B on compute, yet buys "relatively little" compared to rivals Dario Amodei on a live-streamed with JPMorgan's CEO Jamie Dimon as part of Anthropic’s IPO roadshow. Anthropic locks in only a modest, cheaper amount of computing power ahead of time, so it is safe if demand turns out weaker than expected. If demand comes in strong, it will buy extra capacity on the "spot market", which means renting available compute on short notice at the going price, instead of making huge long-term bets upfront. ---- From "CNBC Television" YouTube channel, (link in comment)

    同一件事,精选收录的是《Anthropic CEO Amodei 在 IPO 前承认明年存在巨大不确定性》

10月28日周三
  1. Rohan Paul73

    Anthropic 科学家与 6 家开发新药的组织建立深度研究合作,并启动自有药物发现项目,相关成果仍多处于临床前阶段。据 Rohan Paul 转述,Claude 约一个月生成约 3.5 万个抗体设计,为一家单人生物技术公司协调 11 个外部实验室,并发现人类审查者漏掉的 7 个生产问题。Anthropic 自有项目中的肌营养不良症工作最早可能在 2028 年底进入人体试验。

    引用Anthropic@AnthropicAI

    Over the past few months, Anthropic scientists have engaged in deep research partnerships with six organizations developing new medicines. We've also begun drug discovery efforts of our own. In doing so, we’ve learned much more about how Claude can support the many stages of drug development. In this blog post, we share some early results from these efforts, and describe how this work fits in with our wider ambitions in the life sciences. https://www.anthropic.com/research/early-progress-drug-development

    同一件事,精选收录的是《Anthropic 公布 Claude 参与新药研发进展,最快 2028 年底进入人体临床试验》

11月11日周三
10月30日周五
  1. 宝玉71

    宝玉解读 Anthropic 公布的自我评估(self-assessment)防滥用技术:Claude 每回答完一轮会追加一句简短指令,让它输出一份安全评估,判断对话是否违反使用政策。

    引用Anthropic@AnthropicAI

    We’ve trained Claude to flag potential misuse in conversations, a technique we call self-assessment. Right after it responds, Claude gives a preliminary safety assessment of the conversation. Since we began using self-assessment in June, it has surfaced misuse that our other safeguards weren’t designed to catch. Because Claude has already read the conversation, self-assessment is very efficient. And unlike classifiers, which target a discrete set of harms, it draws on Claude’s own judgment, so it gets more accurate as our models improve. Read more on our new Safeguards blog: https://safeguards.anthropic.com/2026/self-assessment/

    同一件事,精选收录的是《Anthropic 为 Claude 加入自我评估安全检测机制》

11月11日周三
11月20日周五
  1. 宝玉67

    Anthropic 首席执行官 Dario Amodei 在公司首次公开募股之际发表致辞,称上市让公司财务更稳健,也强化了坚持安全优先的决心。他表示将主动把控 AI 系统的训练与部署节奏,不向商业或政治压力低头,并提出以“向上竞速”带动全行业安全建设。致辞还提到 Claude 已被用于蛋白质折叠、药物设计等领域,并称足够强大的 AI 与人类协作有望把百年科学医学进展压缩到十年。

    引用Anthropic@AnthropicAI

    Remarks from Anthropic CEO @DarioAmodei on our initial public offering: My co-founders and I started Anthropic because we believe that the most powerful technology of our time should be built for the benefit of humankind. Daniela and I lost our father to a disease that, just a few years later, became curable. I started my career in biology, hoping to help future cures come sooner. In the lab, I saw the vast thicket of complexity that scientists face when they’re trying to understand disease and develop new treatments. So many of the scientific tools that can cut through that thicket—tools for gene editing, gene synthesis, controlling brain cells with light—started as pure ideas. In other words, they came from thinking. From intelligence. Human intelligence has already made diseases like plague, smallpox, and polio history for most of the world. But progress on other diseases has been too slow for so many patients and their families. Going from a great idea to a treatment can take decades: it took many years from the first discovery of a strange repeating pattern in DNA to the approval of the first treatment for a disease using CRISPR. Nature is full of these patterns. But we’ve had too little intelligence to decipher most of them; too few scientists, with too little time. Now we can build that intelligence. Whether it’s protein folding, drug design, cancer genetics, or clinical trial administration, scientists across many areas of biology and medicine are finding Claude can help them do their research in a fraction of the time it would’ve taken just a couple of years ago. I believe sufficiently powerful AI, working in concert with humans, could compress a century of scientific and medical progress into a decade. I don’t want to get ahead of myself. At this point all we have are early results. Experiments and clinical trials will still take time. And although they involve slow and ponderous processes, I believe those processes can be substantially accelerated by AI. We hope that in the future fewer families miss a cure by just a few years. Medicine is just a particularly vivid example, but there are many others. Our customers—the world’s most ambitious companies, nonprofits, and individual people—are already applying the intelligence we’ve built to stimulate economic growth; lift people out of poverty; protect democracy and free societies; even make everyday services like the DMV work better. We’re proud to work alongside them. And I’m extremely optimistic about what we can do together in the future. At the same time, we have always been honest that this technology has very real risks. These range from misuse of the technology by individuals or nation-states, to economic disruption, to losing control of AI systems. We discuss these risks not because we think they are inevitable, but because we think they are avoidable. Avoiding them depends on the choices made by the people building AI. There is a gigantic difference between how AI will go if we pay little attention to safety, versus how it will go if we are obsessed with safety. And an obsession with safety and with public benefit has been woven into Anthropic’s DNA from the start. From safeguards against biological and cyber risks, to alignment training and testing, to looking inside our models like an X-ray, Anthropic has pioneered methods for understanding and steering the behavior of AI systems. There is much work still to be done, and the most difficult safety work lies ahead of us. The incredible talent of the company that has enabled us to build the most capable AI systems will need to be directed, even more so than it has already, towards double- and triple-checking that those AI systems are safe and secure. And to state it unequivocally, we will pace the training and deployment of AI systems, taking as long as is necessary to have confidence that they are safe and will remain under human control. We will not bend to either business or political pressure. Today puts the company in a stronger financial position, and in doing so only strengthens our resolve to do the right thing. If we can show it’s possible to make the right choices on safety and still build an incredibly successful company, others in our industry will be inspired to do the same. We call this a race to the top. When the race to the top is working properly, it doesn’t matter which company has the best models—everyone wins because everyone is building safely. The race to the top works best when driven from the front of the pack, and we fully hope and expect to do so, but the goal is to make the whole industry better, regardless of whether Anthropic is winning or losing at any given time. The advent of machine intelligence is one of the seminal moments in human history, and we have a rare opportunity to shape it for the better. This moment is bigger than any one company, or any one country. It will take all of us, working together, to ensure this technology goes well for us and the many generations to come. Starting today, we hope that you’ll join us on this mission.

    同一件事,精选收录的是《Anthropic CEO Dario Amodei 就公司 IPO 发表声明》

11月12日周四
11月10日周二
11月6日周五
11月19日周四
11月20日周五
  1. Andrew Curran65

    Anthropic CEO Dario Amodei 就公司启动首次公开募股发表讲话,称上市让公司财务更稳健,也强化其做正确之事的决心。他表示将按需放慢 AI 系统的训练与部署节奏,直到确信系统安全并处于人类控制之下,不会屈从商业或政治压力。他还提到 Claude 已被用于蛋白质折叠、药物设计、癌症遗传学等领域,并称足够强大的 AI 与人类协作有望把百年的科学与医学进展压缩到十年。

    引用Anthropic@AnthropicAI

    Remarks from Anthropic CEO @DarioAmodei on our initial public offering: My co-founders and I started Anthropic because we believe that the most powerful technology of our time should be built for the benefit of humankind. Daniela and I lost our father to a disease that, just a few years later, became curable. I started my career in biology, hoping to help future cures come sooner. In the lab, I saw the vast thicket of complexity that scientists face when they’re trying to understand disease and develop new treatments. So many of the scientific tools that can cut through that thicket—tools for gene editing, gene synthesis, controlling brain cells with light—started as pure ideas. In other words, they came from thinking. From intelligence. Human intelligence has already made diseases like plague, smallpox, and polio history for most of the world. But progress on other diseases has been too slow for so many patients and their families. Going from a great idea to a treatment can take decades: it took many years from the first discovery of a strange repeating pattern in DNA to the approval of the first treatment for a disease using CRISPR. Nature is full of these patterns. But we’ve had too little intelligence to decipher most of them; too few scientists, with too little time. Now we can build that intelligence. Whether it’s protein folding, drug design, cancer genetics, or clinical trial administration, scientists across many areas of biology and medicine are finding Claude can help them do their research in a fraction of the time it would’ve taken just a couple of years ago. I believe sufficiently powerful AI, working in concert with humans, could compress a century of scientific and medical progress into a decade. I don’t want to get ahead of myself. At this point all we have are early results. Experiments and clinical trials will still take time. And although they involve slow and ponderous processes, I believe those processes can be substantially accelerated by AI. We hope that in the future fewer families miss a cure by just a few years. Medicine is just a particularly vivid example, but there are many others. Our customers—the world’s most ambitious companies, nonprofits, and individual people—are already applying the intelligence we’ve built to stimulate economic growth; lift people out of poverty; protect democracy and free societies; even make everyday services like the DMV work better. We’re proud to work alongside them. And I’m extremely optimistic about what we can do together in the future. At the same time, we have always been honest that this technology has very real risks. These range from misuse of the technology by individuals or nation-states, to economic disruption, to losing control of AI systems. We discuss these risks not because we think they are inevitable, but because we think they are avoidable. Avoiding them depends on the choices made by the people building AI. There is a gigantic difference between how AI will go if we pay little attention to safety, versus how it will go if we are obsessed with safety. And an obsession with safety and with public benefit has been woven into Anthropic’s DNA from the start. From safeguards against biological and cyber risks, to alignment training and testing, to looking inside our models like an X-ray, Anthropic has pioneered methods for understanding and steering the behavior of AI systems. There is much work still to be done, and the most difficult safety work lies ahead of us. The incredible talent of the company that has enabled us to build the most capable AI systems will need to be directed, even more so than it has already, towards double- and triple-checking that those AI systems are safe and secure. And to state it unequivocally, we will pace the training and deployment of AI systems, taking as long as is necessary to have confidence that they are safe and will remain under human control. We will not bend to either business or political pressure. Today puts the company in a stronger financial position, and in doing so only strengthens our resolve to do the right thing. If we can show it’s possible to make the right choices on safety and still build an incredibly successful company, others in our industry will be inspired to do the same. We call this a race to the top. When the race to the top is working properly, it doesn’t matter which company has the best models—everyone wins because everyone is building safely. The race to the top works best when driven from the front of the pack, and we fully hope and expect to do so, but the goal is to make the whole industry better, regardless of whether Anthropic is winning or losing at any given time. The advent of machine intelligence is one of the seminal moments in human history, and we have a rare opportunity to shape it for the better. This moment is bigger than any one company, or any one country. It will take all of us, working together, to ensure this technology goes well for us and the many generations to come. Starting today, we hope that you’ll join us on this mission.

    同一件事,精选收录的是《Anthropic CEO Dario Amodei 就公司 IPO 发表声明》

11月17日周二
11月13日周五
11月11日周三
10月25日周日
11月11日周三
10月28日周三
11月19日周四
11月11日周三
11月10日周二
11月2日周一
10月31日周六
  1. 🚨 AI News | TestingCatalog62

    Anthropic 宣布将 Claude Max 5x 更名为 Max、Max 20x 更名为 Ultra,价格分别维持每月 100 美元和 200 美元,现有订阅用户无需操作。已通过验证的 Ultra 账号从当日起取消 5 小时用量限制,较新的账号在完成验证前仍保留临时限制,每周用量上限不变。

    引用Claude@claudeai

    We’re renaming our Max plans: Max 5x → Max Max 20x → Ultra Max is still $100/month, and Ultra is still $200. If you’re a subscriber, there’s nothing you need to do. We’re also removing the 5-hour limit for verified Ultra accounts, starting today with most existing subscribers. Newer accounts keep a temporary limit until they’re verified, which helps us prevent fraud and abuse. You'll get an email when it's removed. Weekly limits remain unchanged. View our plans here: http://claude.com/pricing

10月26日周一
10月25日周日
  1. elvis62

    elvis 转发并评论 Anthropic 关于减少不必要子智能体的指南,认为对多数智能体工作流而言,用工具调用和技能把子智能体折叠进主循环是合理的,因为新模型更持久、更擅长管理大上下文。他仍会在复杂研究任务中通过动态工作流和 /goal 使用子智能体,并强调不能直接删除已有子智能体,而应通过成本、效率等评测决定是否折叠,同时留意工具调用过多、上下文膨胀和职责边界不清等问题。

    引用Tak 🦞@cherry_mx_reds

    Anthropic is now recommending that companies REMOVE unnecessary subagents from their AI systems. This is a pretty significant shift in agent architecture, with their team finding that a single agent equipped with skills can frequently outperform complex multi-agent systems, and one customer seeing roughly 2x faster execution. The emerging rules of thumb: → Skills: Teach the agent HOW to do something, including procedures, expertise, and instructions. → Tools / MCP: Give the agent the ability to DO things through APIs, actions, and live data. → Subagents: Use for parallel work, isolated context, or tasks a single agent struggles with. The interesting part is progressive disclosure. Instead of spawning specialized agents or stuffing everything into a giant prompt, one agent discovers and loads skills and tools as needed. Their advice is to fold existing subagents into the main loop, turn their instructions into skills, expose their actions as tools, and run evals to see if performance holds up. As models have gotten smarter, improving agent architecture is becoming less about what you can add and more about what you can delete. https://claude.com/resources/articles/building-agents-when-to-fold-subagents-into-your-main-agent-loop

11月19日周四
11月18日周三
11月17日周二
11月11日周三